Announcements Trials

Browse Landscape

Phase

Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 62 Breast Neoplasms 44 Prostatic Neoplasms 35 Lung Neoplasms 29 Multiple Myeloma 24 Neoplasms 22 Colorectal Neoplasms 19 Parkinson Disease 4, Autosomal Dominant Lewy Body 18 Ovarian Neoplasms 17 Neoplasm Metastasis 17 Leukemia, Lymphocytic, Chronic, B-Cell 17 Carcinoma, Renal Cell 15 Pancreatic Neoplasms 13 Small Cell Lung Carcinoma 12 Endometrial Neoplasms 12 Urinary Bladder Neoplasms 10 Stomach Neoplasms 10 Squamous Cell Carcinoma of Head and Neck 10 Leukemia, Myeloid, Acute 10 Myasthenia Gravis 9 Lymphoma, Follicular 9 Fallopian Tube Neoplasms 9 Non-Muscle Invasive Bladder Neoplasms 8 Colonic Neoplasms 8 Recurrence 7 Burkitt Lymphoma 7 Lymphoma, Mantle-Cell 6 Esophageal Neoplasms 6 Carcinoma 6 Biliary Tract Neoplasms 6

Interventions

pembrolizumab 1 Pemetrexed 1 Cisplatin 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Advanced Non-small Cell Lung Cancer × 30 days × Clear all

NCT06452277 2026-05-18

SOHO-02

Bayer

Phase 3 Recruiting

Advanced Non-small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡